Stallion India Fluorochemicals : Aggressive Capex
Analysis of this story by ValuePickr · 15 Mar 2026, 11:28 PM IST (about 2 months ago)
AI Analysis
The specialty chemicals sector, particularly fluorochemicals, is witnessing significant growth driven by diverse industrial applications and import substitution initiatives. Increased domestic manufacturing of key components like R-32 aligns with India's 'Make in India' push.
Trading Insight
Key Evidence
- •Stallion India Fluorochemicals is moving into backward integration by manufacturing R-32.
- •The company's current focus is on formulation, blending, debulking, and distribution of fluorochemicals.
- •The backward integration aims to cut down on imports and boost margins.
- •Stallion's products serve diverse industries including automotive, pharmaceuticals, fire safety, defence, power, solar, and semiconductors.
- •Key OEM customers include BlueStar, Voltas, Daikin, LG, and Amber.
Affected Stocks
Aggressive capex for backward integration into R-32 manufacturing, aiming to cut imports and boost margins, indicating future growth potential.
As an OEM customer, increased domestic production of R-32 could lead to more stable supply chains and potentially better pricing.
As an OEM customer, increased domestic production of R-32 could lead to more stable supply chains and potentially better pricing.
As an OEM customer, increased domestic production of R-32 could lead to more stable supply chains and potentially better pricing.
Sources and updates
AI-powered analysis by
Anadi Algo News